On May 14th, the 87th China International Medical Equipment (Spring) Expo was held at the National Exhibition and Convention Center (Shanghai). The exhibition brought together numerous high-quality brands in the industry, showcasing new technologies, solutions, and forces in the medical industry. RYBO also showcased multiple innovative products and solutions, and built various solutions using scene-based approaches to enhance the on-site experience and attract the attention of many industry professionals. It received high praise from industry experts and peers.

As a leader in digital construction and smart healthcare in the medical field, RYBO has accumulated more than ten years of technological exploration and continuous technical deepening. It has developed innovative products and solutions in the management of anesthesia drugs, ward drugs, consumables, testing reagents, and clinical medications. It has demonstrated leadership in the industry and continuously injected driving force into the development of smart healthcare.

Technology empowers to create ultimate product strength. As a company with unique software technology advantages, RYBO has been continuously exploring new tracks for the industry and researching smart healthcare construction needs through cloud computing and big data practices. It has developed products for different stages. The newly developed intelligent dual-sensing reagent cabinet exhibited this time has attracted great attention with its innovative design concepts and powerful application functions. This product has made significant breakthroughs in both reagent management and data coordination, opening up new development directions within the industry and gaining recognition from industry experts.

At the exhibition, RYBO's subsidiary brand “smartrac”, also made a stunning appearance. Smartrac focuses on intelligent devices for anesthesia drug management and has reached a strategic cooperation with Sinopharm Group. Both sides are continuously deepening their efforts in establishing industry standards and digitalizing the entire lifecycle of anesthesia drugs. They are jointly promoting the progress of smart healthcare and promoting the healthy development of the industry.